✦ LIBER ✦

5507 ORAL A phase 2 study of axitinib (AG-013736; AG) in patients (pts) with advanced thyroid cancers

✍ Scribed by Cohen, E.; Vokes, E.E.; Rosen, L.S.; Kies, M.S.; Forastiere, A.A.; Worden, F.P.; Kane, M.A.; Liau, K.F.; Shalinsky, D.R.; Cohen, R.B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of axitinib (AG-013736) in

✍ Jean-Philippe Spano, Malcolm J. Moore, Yazdi K. Pithavala, Alejandro D. Ricart, 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 356 KB

3506 ORAL Axitinib (AG-013736) and gemci

✍ J. Spano; C. Chodkiewicz; J. Maurel; R. Wong; H.S. Wasan; C. Barone; K.F. Liau; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

4507 ORAL Axitinib (AG-013736; AG) in pa

✍ Rini, B.; Wilding, G.; Hudes, G.; Stadler, W.M.; Kim, S.; Tarazi, J.; Bycott, P. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

6551 POSTER Efficacy and safety of singl

✍ von Pawel, J.; Larson, T.; Ou, S.I.; Limentani, S.A.; Sandler, A.B.; Vokes, E.E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Effect of axitinib (AG-013736) on fatigu

✍ Toru Mukohara; Hikaru Nakajima; Hirofumi Mukai; Shunji Nagai; Kuniaki Itoh; Yosh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

Efficacy and Safety of Single-Agent Axit

✍ J.H. Schiller; J. von Pawel; T. Larson; S.I. Ou; S.A. Limentani; A.B. Sandler; E 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 442 KB